Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benzbromarone in Pulmonary Arterial Hypertension
NCT02790450Phase 2Completed
- Sponsor
- Medical University of Graz
- Start
- Oct 2015
- Primary completion
- Aug 2016
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of benzbromarone in pulmonary arterial hypertension (PAH), sponsored by Medical University of Graz. Primary endpoint: Pulmonary vascular resistance at 2 hours. Started Oct 2015; status: completed.
02
Drugs
benzbromarone
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT02790450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02790450.